This finding aligns partially with our previous observations where TNF blockers, such as etanercept and infliximab, did not reduce COX-2 expression in RA synovial tissue, despite their significant inhibitory effects in vitro [23]. This evidence concerns the gene TNF and rheumatoid arthritis.